DMAC R&D Expenses
Diamedica Therapeutics Inc · R&D Expenses
DMAC R&D Expenses
Latest reported$8.15Mperiod ending
DMAC Quarterly R&D Expenses ($0.00 → $8.15M)
Quarterly R&D Expenses
High-resolution chart · PNG
DMAC r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 8,153,000 | |
| 7,987,000 | |
| 6,699,000 | |
| 6,437,000 | |
| 5,822,000 | |
| 5,656,000 | |
| 6,470,000 | |
| 4,983,000 | |
| 3,928,000 | |
| 3,676,000 | |
| 3,677,000 | |
| 3,272,000 | |
| 2,543,000 | |
| 3,618,000 | |
| 2,270,000 | |
| 1,640,000 | |
| 1,955,000 | |
| 1,974,000 | |
| 1,871,000 | |
| 2,332,000 | |
| 2,156,000 | |
| 2,406,000 | |
| 3,120,000 | |
| 2,158,000 | |
| 1,600,000 | |
| 1,349,000 | |
| 1,802,000 | |
| 1,617,000 | |
| 1,874,000 | |
| 2,607,000 | |
| 2,407,937 | |
| 1,210,000 | |
| 1,070,000 | |
| 791,000 | |
| 646,234 | |
| 490,102 | |
| 912,674 | |
| 1,156,990 | |
| 423,589 | |
| 740,789 | |
| 368,356 | |
| 239,599 | |
| 263,787 | |
| 146,484 | |
| 203,111 | |
| 88,099 | |
| 420,985 | |
| 729,972 | |
| 944,556 | |
| 1,259,200 | |
| -1,701,577 | |
| 1,167,174 | |
| 1,892,259 | |
| 1,470,161 | |
| -851,913 | |
| 2,288,967 | |
| 2,012,980 | |
| 737,170 | |
| -1,619,410 | |
| 1,365,961 | |
| 1,327,449 | |
| 1,431,889 | |
| 294,457 | |
| 165,296 | |
| 138,523 | |
| 204,774 | |
| 318,401 | |
| 387,758 | |
| 169,444 | |
| 402,401 | |
| -224,265 | |
| 558,783 | |
| 459,582 | |
| 271,044 | |
| -111,300 | |
| 246,217 | |
| 412,925 | |
| 103,175 | |
| 147,310 | |
| 156,648 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |